← Back to All Filings

LLY: 10% Owner Lilly Endowment Sells $479K in Stock

Low SignificanceNovember 5, 2025 at 4:02:24 PM EST

ELI LILLY & Co

$LLY4CIK: 0000059478

Subscribe to track LLY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

LLY: 10% Owner Lilly Endowment Sells $479K in Stock

Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-05 Significance: Low

Insider: LILLY ENDOWMENT INC Title: N/A | Relationship: 10% Owner

Transaction: • Type: Sale • Shares: 526 • Price: $910.72 • Value: $479,038 • Owned After: 93,931,452

Key Insight: A 10% owner made a very small, routine sale, representing a negligible fraction of its total holdings (0.0006%) and the company's market cap (0.00006%).

Market Context: This transaction is immaterial for a mega-cap pharmaceutical company like Eli Lilly. The insider remains a top shareholder with nearly 10% ownership post-transaction.

Comprehensive Analysis

SEC Filing Analysis: ELI LILLY & Co (LLY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A 10% owner, Lilly Endowment Inc., executed a minor sale of approximately $479K in LLY stock, which is insignificant relative to its massive holding and the company's $811.66B market cap.
  • Market Impact: Negligible. This transaction is considered routine and carries no significant market signal.

Company Information

FieldValue
CompanyELI LILLY & Co
Ticker SymbolLLY
CIK0000059478
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameLILLY ENDOWMENT INC
CIK0000316011
Title/PositionN/A
Relationship10% Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-04
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved526
Price Per Share$910.719
Total Value$479,038.19
Shares Owned After93,931,452
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$479,038.19
% of Market Cap0.00006%
Shares Transacted526
% of Shares Outstanding0.00006%
Post-Transaction Ownership93,931,452 shares (9.92% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The ~$479K sale is trivial for an $811.66 billion mega-cap company like Eli Lilly.
  • Ownership Concentration: Lilly Endowment remains a substantial shareholder, holding 9.92% of all outstanding shares even after this minor sale. The sale represented less than 0.001% of its total holdings.
  • Transaction Significance: The transaction is statistically insignificant against all key metrics (% of market cap, % of shares outstanding, % of insider's holdings) and is considered routine.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is far too small to influence market perception or stock price. It is likely for portfolio rebalancing or liquidity purposes by the Endowment, not a change in outlook.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction size is a tiny fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. The filing provides no bullish or bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: The filing footnote indicates the price is a weighted average from multiple trades, which is common for institutional dispositions.
  • Market Environment: This is a routine transaction that does not signal any change in the insider's long-term view of the company.
Topics:#SECFiling#InsiderTrading#LLY#EliLilly#Form4#InsiderSell#StockMarket#Investing#LillyEndowment#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.